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Available online 30 April 2016Assess whether receipt of tailored printouts generated by the Cancer Risk Intake System (CRIS) – a touch-screen
computer program that collects data from patients and generates printouts for patients and physicians – results
in more reported patient-provider discussions about colorectal cancer (CRC) risk and screening than receipt of
non-tailored information.
Cluster-randomized trial, randomized by physician, with data collected via CRIS prior to visit and 2-week follow-
up telephone survey among 623 patients.
Patients aged 25–75 with upcoming primary-care visits and eligible for, but currently non-adherent to CRC
screening guidelines.
Patient-reported discussions with providers about CRC risk and testing.
Tailored recipientsweremore likely to report patient-physician discussions about personal and familial risk, stool
testing, and colonoscopy (all p b 0.05). Tailored recipients were more likely to report discussions of: chances of
getting cancer (+10%); family history (+15%); stool testing (+9%); and colonoscopy (+8%) (all p b 0.05).
CRIS is a promising strategy for facilitating discussions about testing in primary-care settings.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Tailoring1. Introduction
Colorectal cancer (CRC) testing can prevent mortality (U.S.
Preventive Services Task Force, 2008) but participation in testing is
too low (Smith et al., 2014; Holden et al., 2010). Patients have limited
knowledge about need for and beneﬁts of testing (Guerra et al., 2005;
Doubeni et al., 2010; Beydoun and Beydoun, 2008). Physicians' recom-
mendations are strong predictors of testing (Sarfaty and Wender,
2007; Wee et al., 2005; Klabunde et al., 2005; O'Malley et al., 2004)
but recommendation rates remain suboptimal.
Providers may have difﬁculty determining what type and schedule
of testing is appropriate for patients' particular risk levels, becauseCenter, 5323 Harry Hines Blvd.,
C.S. Skinner).
. This is an open access article underfamily and personal risk factors (e.g., number, size, and histology of
polyps or family members' ages at diagnosis) (Winawer et al., 2003)
are not routinely documented in patients' charts. This may be especially
true for patients whose risk levels warrant screening before age 50.
There is little information about howmany of these younger individuals
would beneﬁt from screening, what type they should have, or preva-
lence of physician recommendations for screening. However, there is
reason to believe that screening among younger at-risk individuals is
lower than among those over 50. 2010 National Health Interview data
showed colonoscopy rate among ﬁrst-degree relatives ages 40 to 49
(38.3%) was about half of those 50 and older (69.7%) (Tsai et al.,
2015). Collecting and evaluating risk information during an ofﬁce visit
can be too time-consuming and complicated (Burke, 2005; Suther and
Goodson, 2003) for routine practice.
We developed the Cancer Risk Intake System (CRIS)— a touch-screen
program that collects data prior to ofﬁce visits and generates printoutsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tors; guideline-based recommendations for test modality, age at initia-
tion, and schedule; and patient concerns about testing. By providing
an individually tailored intervention at the point of care delivery, CRIS
was meant to be a helpful and unobtrusive adjunct to clinical care.
2. Materials and methods
2.1. Overview
In this cluster-randomized trial, physicians were randomly assigned
to receive CRIS-tailored printouts outlining patients' speciﬁc risk factors,
guideline-based testing options, and concerns about testing, or a stan-
dard chart prompt for patients ≥50 and not recently screened. Based
on assignment of their physicians, patients used CRIS and received tai-
lored (n= 329) or non-tailored (n= 322) printouts. To mask the pur-
pose of CRIS for the non-tailored comparison group, data collection
included questions about multiple cancers, not only CRC. Overall goal
of the study was compare screening outcomes between the CRIS tai-
lored and non-tailored groups as well as a third group that did not use
CRIS and received no contact. However, as amechanism for understand-
inghow the CRIS tailored interventionmight ultimately increase screen-
ing,we also assessedwhether it prompted patient-provider discussions.
Here we report results from patient telephone surveys conducted with
623 patients from the tailored and non-tailored groups two weeks
after the ofﬁce visit during which they used the CRIS. Data were col-
lected by Research Assistants, blinded to participants' random
assignment.
2.2. Setting
The study, approved by the University of Texas Southwestern Med-
ical Center Institutional Review Board and registered on clinicaltrials.
gov, enrolled insured patients seen in the general internal medicine fac-
ulty clinic and the family medicine faculty clinic at the University of
Texas Southwestern (UTSW) Medical Center. A UTSW electronic medi-
cal records system administrator developed a query to identify poten-
tially eligible patients with upcoming appointments.
2.3. Eligibility criteria
We sought to enroll patients whowere eligible for, but not adherent
to, CRC testing based on national guidelines (U.S. Preventive Services
Task Force, 2008; Smith et al., 2014; Levin et al., 2008). We invited pa-
tients younger than 50 because CRIS algorithms identify those whose
risks warrant early testing due to personal history of polyps or inﬂam-
matory bowel diseases, or family history of polyps or cancer. For lower
age limit, we selected 25 — the age by which the National Comprehen-
sive Cancer Network at the time of study initiation recommended be-
ginning colonoscopy among carriers of mutations for the Lynch
syndrome, the most common hereditary cancer syndrome (Lynch
et al., 2004). For patients b50, research assistants (RAs) conducted
screening during recruitment calls to identify potentially eligible partic-
ipants with CRC family history, personal history of inﬂammatory bowel
disease, or adenomatous polyps. We asked about these risk factors dur-
ing this phone screening process because they are not reliably collected
and entered into patients' electronic medical records.We selected 75 as
the upper age for inclusion(U.S. Preventive Services Task Force, 2002)
and excluded those who had no telephone access and were unable to
speak or read English.
2.4. Study design
The study has been explained in detail elsewhere (Skinner et al.,
2015a) and is summarized here. Physician was the unit of random as-
signment. We used the SAS PROC Plan (SAS, 2014) procedure torandomly assign physicians either to CRIS-tailored or non-tailored
group using permuted-block randomization with varying block sizes;
their patients were therefore pre-identiﬁed as CRIS-tailored or non-
tailored group members before they were invited (Those identiﬁed as
members of a no-contact control group were, by deﬁnition, never
contacted and are not included in this report of outcomes from the tele-
phone survey). Identiﬁed patients with upcoming appointments (n =
10,216) received letters signed by the clinic medical director saying
they “might be invited” for participation in a “study of beliefs and prac-
tices about cancer prevention and early detection.” After oneweek dur-
ing which 96 opted out of contact, research assistants (RAs) called
patients to explain the study, verify eligibility and, if patients agreed, ar-
range in-person meetings 30 min before appointments. Of 2989 poten-
tially eligible patients reached and invited, 1032 agreed to participate
and 935 arrived in time to use CRIS.
Research Assistants (RA) met patients in the clinic waiting room to
obtain consent and facilitate use of the CRIS program on a touch-
screen tablet computer. After completion, patients gave the tablet
back to the RA, who connected it with a printer to generate the print-
outs. RAs handed the patient's printout directly to the patient and
placed the physician's printout with the patient's demographic sheet
— the only piece of paper used for the clinic encounter.
CRIS collected demographics, personal history including previous
testing, detailed family history, and concerns about testing, then
used these data to determine ﬁrst whether any testing was currently
needed. Of the 935 who completed the CRIS, 651 were in need of
testing. For these, CRIS determined risk-appropriate testing
option(s) and generated the tailored or non-tailored printouts. RAs
conducted telephone interviews with 95.7% (623/651) of partici-
pants within 2 weeks of the ofﬁce visit. Participants received a $10
gift card for completing the CRIS and $15 for completing the 2-
week telephone interview.
2.5. Interventions and measures
Sample CRIS-tailored printouts appear in Fig. 1. Each includes: sum-
mary of patient's CRC risks, appropriate test(s) based on self-reported
risk factors, and concerns about testing. Consistentwith health behavior
theory (Skinner et al., 2015b), the patient's version portrays elevated
risk factors with a graphic, includes a statement about testing beneﬁts
along with which type of testing is guideline-based, and includes brief
messages designed to address concerns. Physicians' printouts list risk
factors, guideline-based testing option(s), and the patient's concerns.
Because data entered into the program are only as accurate as users'
knowledge and memory, a statement explains the information is
based on patient report on the speciﬁc date.
Patients in the non-tailored group received text from the American
Cancer Society brochure (about multiple types of screening) inserted
into a format similar to the tailored printouts; their physicians received
the UT Southwestern “best practice” electronic prompt for patients 50
and older with no documentation of CRC screening.
To assess topics of discussion during the visit, Research Assistants
read: These next questions are about what you and your doctor talked
about during your visit. I′ll read a list. You probably didn't talk about all
of these, but you may have talked about some. For each please answer
yes, no, or you can't remember. They then read the topics shown in
Table 2, which lists percentages answering “yes” to each.
2.6. Statistical analysis
To test differences in reported discussions about cancer risk and test-
ing, baseline variables were analyzed using generalized linear mixed
models including physician as a random cluster effect. The ﬁnal analyt-
ical sample was 623 patients (n = 314 tailored and n = 309 non-
tailored).
Fig. 1. Sample printouts (patient sample on left and physician sample on right).
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In the tailored and non-tailored groups, participants were similarly
and primarily non-Hispanic White (62% and 67.7%, respectively), and
female (62.3% and 67.1%, respectively). See Table 1. In both groups,
just over half had at least four years of college (50.2% and 53.1%, respec-
tively). Mean age in tailored group was slightly younger (57.5 v.
59.1 years; p=0.038). Numbers of patients under age 50 who, accord-
ing to their reported risk factors were due for screening, were similarly
small in the tailored (n= 35) and non-tailored (n= 22) groups (10.6%
v. 6.8%; p= .086) (Skinner et al., 2015a). Unemployment was lower in
the tailored group (27.1% v. 40.7%, p= .0003).Table 1
Baseline patient characteristics by tailored and non-tailored groups.
Tailored
n = 329
n (%)
Non-tailored
n = 322
n (%)
p-Valuea
Age, mean (±SD) 57.5 (±8.6) 59.1 (±7.9) 0.038
Race/Ethnicity 0.529
Hispanic 31 (9.4) 26 (8.1)
NH White 205 (62.3) 218 (67.7)
NH Black 76 (23.1) 63 (19.6)
Asian/Indian/PI 13 (4.0) 10 (3.1)
Other/Refused 4 (1.2) 5 (1.6)
Gender 0.797
Female 205 (62.3) 216 (67.1)
Male 124 (37.7) 106 (32.9)
Educationb 0.452
b4 years of college 163 (49.5) 151 (46.9)
≥4 years of college 165 (50.2) 171 (53.1)
Employmentb 0.0003
Full or part-time 239 (72.6) 191 (59.3)
Unemployed 89 (27.1) 131 (40.7)
SD: Standard Deviation; NH: Non-Hispanic; PI: Paciﬁc Islander.
a Clinical provider is included as a random cluster effect in the model.
b One patient refused education (tailored group); one patient refused employment
(tailored group).As shown in Table 2, there were signiﬁcant between-group differ-
ences in patient-reported discussions with providers. Tailored recipi-
ents were more likely to report discussions about getting cancer (p=
.004), family history (p = .014), and having a stool test (p = .011)
and colonoscopy (p= .025).4. Conclusions
4.1. Discussion
Patients in the CRIS-tailored group reported more discussion about
CRC risk and testingwith their physicians during the ofﬁce visit. The tai-
lored patient printed materials, combined with the tailored physician's
version (in contrast to only the electronic “best practice” prompt re-
ceived by physicians in the non-tailored group) may have provided
more guidance about topics to discuss during the visit. Particularly ro-
bust increases were noted for discussion of family history of cancer, as
well as chances of getting cancer.Table 2
Comparison of patient discussions of cancer risk and testing with their provider.
Discussion topic Tailored
n =
314
%
Non-tailored
n = 309
%
Odds ratio
(95% CI)
p-Valuea
Chances of getting cancer 27 17 1.9 (1.2–2.9) 0.004
Family history of cancer 40 25 1.9 (1.1–3.1) 0.014
Meeting genetic counselor 5 4 1.4 (0.6–3.0) 0.447
Having a stool blood test 30 21 1.6 (1.1–2.3) 0.011
Having a ﬂexible
sigmoidoscopy
18 15 1.3 (0.8–2.1) 0.307
Having a colonoscopy 74 66 1.5 (1.0–2.2) 0.025
Having a CT colonography 9 5 1.8 (0.9–3.4) 0.066
Having a barium enema 6 4 1.7 (0.8–3.6) 0.177
CI: Conﬁdence interval.
a Non-tailored group is the reference group. Clinical provider is included in model as a
random cluster effect.
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tion for or completion of guideline-based testing, but such discussions
have been shown to predict participation in screening (Sohler et al.,
2015). Recent studies have shown that that use of a narrative interactive
computer program about CRC screening before a visit led to more dis-
cussion about screening than receipt of a non-tailored brochure
(Christy et al., 2013), and a physician-patient interventionwasmore ef-
fective than a physician-only intervention for increasing rates of CRC
screening discussion (Dolan et al., 2015). Findings are also consistent
with a previous quasi-experimental (pre-post) pilot test conducted
with an earlier version of CRIS (Skinner et al., 2005) in which patient-
provider discussions increased after CRIS and its tailored printouts
were introduced into the clinic, compared to before. However, because
that study did not compare a tailored v. non-tailored printout, it is only
now through the randomized trial that we are able to determine that it
was the tailored content, rather than the experience of using CRIS and
receiving any printed materials, that seem to have facilitated the
discussions.
4.2. Limitations
Data reported here are limited to the 623 patients who agreed to
participate, arrived in time to use CRIS for data collection prior to their
appointments, and completed the 2-week telephone survey. Outcome
for those who, for whatever reason, did not participate when invited,
may have differed.
Although previous research has demonstrated reasonable accuracy
in reporting family history (Murff et al., 2004) and CRC screening
(Baier et al., 2000), to the extent that patients were mistaken about
CRIS responses, accuracy of the resulting guideline recommendations
could have been compromised. Our ﬁndings are only applicable to pa-
tients and physicians receiving reports based on risk factors reported
by patients, just prior to an ofﬁce visit.
The fact that patient-physician discussionswere self-reported is also
a limitation of our ﬁndings. Self-reports, while often assessed in inter-
vention trials (Skinner et al., 2015b; Christy et al., 2013), do not always
equate with observed discussions (Carroll et al., 2008). Therefore, we
can only conclude that more patients in the tailored group perceived
and reported discussions than those in the non-tailored group. Also, be-
cause the items literally measured self-report of topics discussed during
the visit, we must note that the reported discussion may or may not
have included a screening recommendation.
Finally, data from this trial do not tell us what prompted reported
discussions — tailored information to the patient, the physician, or
both? We know that the print outs were given to all patients who
used CRIS and to physicians in the tailored group but there was likely
variation in how much attention each gave to his or her printout.
More study is needed to determine the mechanism of action.
5. Conclusion
Patients' use of CRIS and they and their physicians' receipt of tailored
printouts led to more reported discussion about CRC risk and screening
than patients receiving a non-tailored print out following CRIS use and
their physicians getting a standard chart prompt. CRIS is a promising
strategy for facilitating discussions about risk-based testing in
primary-care settings. Programs like CRIS, with ability to collect risk in-
formation and particular patient concerns, may become increasingly
important with the advent of more personalized medicine and inher-
ently complex screening decisions.
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